Envoy Medical, Inc.
COCH· Nasdaq
Filed May 15, 2023 · 10-Q · 45 days after period end · 0001104659-23-060855
| Metric | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|
| Revenue | $78.00K | — | — |
| Net Income | -$13.25M | -$1.87M | -$1.47M |
| EPS Diluted | -$1.31 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 15, 2023 · 45 d after period end